DE602004029907D1 - Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung - Google Patents

Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung

Info

Publication number
DE602004029907D1
DE602004029907D1 DE602004029907T DE602004029907T DE602004029907D1 DE 602004029907 D1 DE602004029907 D1 DE 602004029907D1 DE 602004029907 T DE602004029907 T DE 602004029907T DE 602004029907 T DE602004029907 T DE 602004029907T DE 602004029907 D1 DE602004029907 D1 DE 602004029907D1
Authority
DE
Germany
Prior art keywords
sulfonamide
crystal
production
indol compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004029907T
Other languages
German (de)
English (en)
Inventor
Keiko Takahashi
Kenji Hayashi
Taichi Abe
Takao Omae
Takashi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of DE602004029907D1 publication Critical patent/DE602004029907D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004029907T 2003-09-10 2004-09-01 Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung Expired - Lifetime DE602004029907D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003318953 2003-09-10
PCT/JP2004/012649 WO2005026118A1 (ja) 2003-09-10 2004-09-01 スルホンアミド含有インドール化合物の結晶およびその製造方法

Publications (1)

Publication Number Publication Date
DE602004029907D1 true DE602004029907D1 (de) 2010-12-16

Family

ID=34308544

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029907T Expired - Lifetime DE602004029907D1 (de) 2003-09-10 2004-09-01 Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung

Country Status (24)

Country Link
US (2) US7754894B2 (enExample)
EP (1) EP1666463B1 (enExample)
JP (1) JP4435090B2 (enExample)
KR (1) KR20060120644A (enExample)
CN (2) CN100406440C (enExample)
AT (1) ATE486849T1 (enExample)
AU (1) AU2004272400B2 (enExample)
BR (1) BRPI0414314A (enExample)
CA (1) CA2536995C (enExample)
CY (1) CY1110975T1 (enExample)
DE (1) DE602004029907D1 (enExample)
DK (1) DK1666463T3 (enExample)
ES (1) ES2354286T3 (enExample)
HR (1) HRP20100631T1 (enExample)
IL (2) IL174059A0 (enExample)
MX (1) MXPA06002732A (enExample)
NO (1) NO335256B1 (enExample)
NZ (1) NZ546111A (enExample)
PL (1) PL1666463T3 (enExample)
PT (1) PT1666463E (enExample)
RU (1) RU2336269C2 (enExample)
SI (1) SI1666463T1 (enExample)
TW (1) TW200514770A (enExample)
WO (1) WO2005026118A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2336269C2 (ru) * 2003-09-10 2008-10-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Кристаллическое индолсульфонамидное соединение и способ его получения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3868534B2 (ja) * 1996-05-24 2007-01-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド誘導体の製造法および中間体
JP2000247949A (ja) 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
JP4039856B2 (ja) * 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
TWI283575B (en) * 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent
RU2336269C2 (ru) * 2003-09-10 2008-10-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Кристаллическое индолсульфонамидное соединение и способ его получения

Also Published As

Publication number Publication date
EP1666463A1 (en) 2006-06-07
AU2004272400A1 (en) 2005-03-24
TWI349663B (enExample) 2011-10-01
NO335256B1 (no) 2014-10-27
CY1110975T1 (el) 2015-06-11
JPWO2005026118A1 (ja) 2007-11-08
EP1666463A4 (en) 2007-12-12
NZ546111A (en) 2008-11-28
NO20061545L (no) 2006-06-09
JP4435090B2 (ja) 2010-03-17
TW200514770A (en) 2005-05-01
RU2336269C2 (ru) 2008-10-20
US20070082941A1 (en) 2007-04-12
RU2006111454A (ru) 2006-08-27
PT1666463E (pt) 2011-01-17
BRPI0414314A (pt) 2006-10-31
US20090247768A1 (en) 2009-10-01
AU2004272400B2 (en) 2010-03-04
IL174059A0 (en) 2006-08-01
CN1849305A (zh) 2006-10-18
CN100406440C (zh) 2008-07-30
CA2536995A1 (en) 2005-03-24
EP1666463B1 (en) 2010-11-03
IL196569A0 (en) 2011-07-31
MXPA06002732A (es) 2006-06-05
WO2005026118A1 (ja) 2005-03-24
US7754894B2 (en) 2010-07-13
SI1666463T1 (sl) 2011-02-28
KR20060120644A (ko) 2006-11-27
ES2354286T3 (es) 2011-03-11
CA2536995C (en) 2013-12-17
HK1092796A1 (en) 2007-02-16
ATE486849T1 (de) 2010-11-15
DK1666463T3 (da) 2010-12-20
PL1666463T3 (pl) 2011-04-29
HRP20100631T1 (hr) 2010-12-31
CN101165049A (zh) 2008-04-23

Similar Documents

Publication Publication Date Title
MY132094A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
SE0202430D0 (sv) New Compounds
NO20065503L (no) Indolyderivater som lever-X-resptormodulatorer.
CY1111410T1 (el) Αναστολεις τουμπουλινης
CY1112780T1 (el) Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac
EP1649955A4 (en) DIAMOND FILM COATED TOOL AND METHOD OF PRODUCING THE SAME
EP1522612A4 (en) COMPOUND III-V SEMICONDUCTOR CRYSTAL AND PROCESS FOR PRODUCING THE SAME
GEP20074209B (en) Multi-substitued selective androgen receptor modulators and methods of use thereof
MY138826A (en) 2,7-substituted indoles
SI1279665T1 (sl) Postopek za pripravo perindoprila, njegovih analogov in njegovih soli, z uporabo 2,5-diokso-oksazolidin-intermediatnih spojin
ATE496046T1 (de) Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
AT5704U3 (de) Stopfpickel und verfahren zu dessen herstellung
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
DE60336066D1 (de) 1,7,8-trifluornaphthalin-2-naphthol und verfahren zur herstellung von flüssigkristallinen verbindungen unter dessen verwendung
DE69901689D1 (de) Salze der ketosäuren und amine sowie ihre verwendung zur herstellung von medikamenten
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
DE602004029907D1 (de) Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung
MXPA05006957A (es) Nuevos derivados de fosforamida.
DK1553967T3 (da) Anvendelse af et amidderivat af GE 2270 faktor A3 til behandling af acne
MY135169A (en) NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DK1546096T3 (da) Fremgangsmåde til fremstilling af aminopyrrolidinderivater